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diagnostic challenge as standard nerve conduction studies cannot
evaluate Ad and C-fibre function. Thermal threshold quantitative
sensory testing (QST) using the method of limits is an indirect
assessment technique that can help in this situation. This has been
augmented by the recent determination of normative age-
dependent values in a large, age-diverse cohort at our centre
(Hafner et al., 2015).
In that study, we tested for but found no evidence of machine
differences when the same operator was testing a small cohort in
a crossover design. However, the possibility remained for operator
differences to account for some variability between repeat tests on
the same machine that was not sufficiently addressed in this pre-
vious work, given its small sample size. Therefore, we conducted
the present study to establish if operator differences could be
detected when subjects were crossed over using the same machine
with a larger cohort.
This study was approved by the local ethics committee and
complied with the 2013 update of the Declaration of Helsinki. All
subjects provided written informed consent.
Thirty-two normal volunteers aged 17–66 years (median age
29.5 years) participated. The modified Marstock method of limits
(Fruhstorfer et al., 1976) was used to record thermal thresholds
for warm (WDT) and cool detection (CDT) at the thenar eminence
of the right hand and over the dorsolateral aspect of the right foot.
Initial data were collected on individuals after randomisation toone of two investigator groups (operator RB-F in group 1, operators
SC or AL in group 2) using the same Medoc Thermal Sensory
Analyser II Machine (Medoc, Ramat Yishai, Israel). All tests were
performed in the same room with the subject supine using identi-
cal scripted instructions. The testing methodology was performed
as reported previously (Hafner et al., 2015). A thermode with a
temperature range between 0 C–50 C using the Peltier effect
was applied to each area of skin examined. After a temperature
adaptation period at 32 C, subjects pressed a button in response
to the first sensation of temperature change. Five trials were con-
ducted per modality per site and the results averaged to yield
the final threshold value.
Subjects then underwent repeat testing by an investigator
belonging to the alternate group blinded to the results of previous
testing at least 21 days after the first test in order to minimise
learning effects. All investigators were formally trained on machine
operation. However, the Group 2 investigators (SC and AL) pos-
sessed extensive clinical experience with thermal threshold QST,
whereas RB-F had performed less than five clinical studies using
this method prior to the commencement of this study.
Statistical analysis was performed using SAS (SAS Institute Inc.,
Cary, NC, USA). T-tests were used to test for intra-subject
differences between operators, and for period and carryover effects
(an effect of the operator for the first test that carries over to the
second test). One subject was excluded from all analyses due to
outlying values.
We did not find evidence for a difference in mean temperature
thresholds between operators. The estimates for the difference in
mean operator effects (Group 1 minus Group 2), confidence
Table 1
Operator (Group 1 minus Group 2), carryover and period effect size results (first test minus second test). Mean temperature differences are in C. ICC >0.75 is taken as excellent,
0.60–0.75 as good, 0.40–0.59 as fair and <0.40 as poor (Shrout and Fleiss, 1979).





Difference in mean period
effects (95% CI) (C); P-value
Intraclass correlation
coefficient (grade)
Hand Warm 0.04 (0.26–0.18); P = 0.73 0.16 0.12 (0.10–0.34); P = 0.28 0.68 (Good)
Cool 0.02 (0.09–0.12); P = 0.74 0.30 0.04 (-0.06–0.15); P = 0.42 0.84 (Excellent)
Foot Warm 0.06 (0.99–1.12); P = 0.90 0.20 0.14 (0.92–1.19); P = 0.79 0.58 (Fair)
Cool 0.14 (0.20–0.47); P = 0.41 0.24  0.10 (0.43–0.24); P = 0.56 0.86 (Excellent)
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and their CIs were small in comparison to the size of the observed
thresholds. Similarly, there was no evidence for a difference in car-
ryover effects between the patients tested, dependent on the
investigator administering the first test or period effects between
the first and second tests (Table 1).
Thermal threshold testing, employing cool and warm detection,
is a one of few readily available methods in the armamentarium of
diagnostic neurophysiological testing for small fibre neuropathies.
By contrast, the determination of thermal pain thresholds is less
reliable in this regard due to the relatively increased variability
of measurements therein (Ng Wing Tin et al., 2014). Microneurog-
raphy remains a research tool. It is particularly advantageous in
that it is non-invasive, well tolerated by subjects and for its relative
ease of administration. Furthermore, intra-rater (Knutti et al.,
2014) and inter-observer reliability (Geber et al., 2011) has been
shown to be good-to-excellent using the method of limits in recent
studies of similar design. Though it may be a less sensitive tool
than intraepidermal nerve fibre density (IENF) measurement by
skin biopsy, an accurate diagnosis of small fibre neuropathy might
depend on abnormal QST results in a small but significant propor-
tion of affected persons in whom IENF density is not reduced
(Devigili et al., 2008).
The results of our study suggest that differences between exam-
iners, carryover or period effects do not contribute significantly to
variation in measurements when conditions are standardized and
the testing interval is at least three weeks. The lack of apparent
observer variation despite the disparity in the level of practical
technical experience between examiner groups is also notable,
being relatively infrequently detailed in the QST literature
(Moloney et al., 2011). This however is contingent on operators
receiving adequate preparatory training on equipment use.
Further studies are needed to examine whether differences in
observers remain insignificant when testing persons with
known small fibre neuropathy, as there is known to be more
intra-individual variability on serial testing (Bravenboer et al.,
1992; Moravcová et al., 2005), and absolute threshold values in
these individuals are significantly larger compared to those in
our cohort. However, our study findings are encouraging for thebroader implementation of this testing modality in practice both
in clinical and research settings, where collaboration between
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